Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
Oligonucleotide therapeutics that can modulate gene expression have been gradually developed for clinical applications over several decades. However, rapid advances have been made in recent years. Artificial nucleic acid technology has overcome many challenges, such as (1) poor target affinity and s...
Saved in:
Main Authors: | Chisato Terada (Author), Seiya Kawamoto (Author), Asako Yamayoshi (Author), Tsuyoshi Yamamoto (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
by: Tsuyoshi Yamamoto, et al.
Published: (2021) -
Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids
by: Yu Mikame, et al.
Published: (2023) -
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
by: Fumito Wada, et al.
Published: (2021) -
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
by: Shintaro Fumoto, et al.
Published: (2021) -
Development of Antibody-Oligonucleotide Complexes for Targeting Exosomal MicroRNA
by: Asako Yamayoshi, et al.
Published: (2020)